Frontiers in Cellular and Infection Microbiology· 2018Q1· Review
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
- 1,284citations
- Q1SCImago
- 2018year
Short summary
The gut microbiota significantly influences intestinal immunity by modulating tryptophan (Trp) metabolism, affecting both host and bacterial Trp metabolites. These metabolites, particularly those acting as aryl hydrocarbon receptor (AhR) ligands, are crucial for maintaining immune homeostasis.
AI-generated from the title and abstract; the full text is not read.
Key points
- Gut microbiota alters host immunity by modulating tryptophan metabolism.
- Both endogenous and bacterial tryptophan metabolites affect gut immunity.
- Tryptophan metabolites, particularly AhR ligands, are vital for intestinal immune homeostasis.
- Factors like aging, stress, and diseases can alter tryptophan metabolism and gut immunity interactions.
AI-generated from the title and abstract; the full text is not read.
Abstract
The gut microbiota influences the health of the host, especially with regard to gut immune homeostasis and the intestinal immune response. In addition to serving as a nutrient enhancer, L-tryptophan (Trp) plays crucial roles in the balance between intestinal immune tolerance and gut microbiota maintenance. Recent discoveries have underscored that changes in the microbiota modulate the host immune system by modulating Trp metabolism. Moreover, Trp, endogenous Trp metabolites (kynurenines, serotonin, and melatonin), and bacterial Trp metabolites (indole, indolic acid, skatole, and tryptamine) have profound effects on gut microbial composition, microbial metabolism, the host's immune system, the host-microbiome interface, and host immune system-intestinal microbiota interactions. The aryl hydrocarbon receptor (AhR) mediates the regulation of intestinal immunity by Trp metabolites (as ligands of AhR), which is beneficial for immune homeostasis. Among Trp metabolites, AhR ligands consist of endogenous metabolites, including kynurenine, kynurenic acid, xanthurenic acid, and cinnabarinic acid, and bacterial metabolites, including indole, indole propionic acid, indole acetic acid, skatole, and tryptamine. Additional factors, such as aging, stress, probiotics, and diseases (spondyloarthritis, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer), which are associated with variability in Trp metabolism, can influence Trp-microbiome-immune system interactions in the gut and also play roles in regulating gut immunity. This review clarifies how the gut microbiota regulates Trp metabolism and identifies the underlying molecular mechanisms of these interactions. Increased mechanistic insight into how the microbiota modulates the intestinal immune system through Trp metabolism may allow for the identification of innovative microbiota-based diagnostics, as well as appropriate nutritional supplementation of Trp to prevent or alleviate intestinal inflammation. Moreover, this review provides new insight regarding the influence of the gut microbiota on Trp metabolism. Additional comprehensive analyses of targeted Trp metabolites (including endogenous and bacterial metabolites) are essential for experimental preciseness, as the influence of the gut microbiota cannot be neglected, and may explain contradictory results in the literature.
The authors' abstract, as published at the source. Frontiers in Cellular and Infection Microbiology, 2018 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biological Psychiatry
Biological PsychiatryNeuroscience